NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 165 filers reported holding NEKTAR THERAPEUTICS in Q4 2014. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,889,000 | -56.0% | 172,306 | -49.9% | 0.89% | -36.3% |
| Q2 2015 | $4,298,000 | -33.7% | 343,670 | -41.7% | 1.39% | -11.0% |
| Q1 2015 | $6,479,000 | +19.9% | 589,260 | +69.1% | 1.56% | +9.9% |
| Q4 2014 | $5,402,000 | +94.9% | 348,419 | +51.8% | 1.42% | +43.8% |
| Q3 2014 | $2,772,000 | – | 229,577 | – | 0.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Strong Tower Advisory Services | 404,972 | $6,913,000 | 4.02% |
| GREAT POINT PARTNERS LLC | 504,691 | $9,064,000 | 2.11% |
| Camber Capital Management LP | 3,750,000 | $67,350,000 | 2.07% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,901,000 | 1.50% |
| Rhenman & Partners Asset Management AB | 950,000 | $17,062,000 | 1.20% |
| MAVERICK CAPITAL LTD | 5,838,426 | $104,858,000 | 1.06% |
| Birchview Capital, LP | 72,000 | $1,293,000 | 0.88% |
| Bellevue Group AG | 4,594,656 | $82,519,000 | 0.84% |
| CM Management, LLC | 50,000 | $898,000 | 0.67% |
| Duquesne Family Office | 1,000,000 | $17,960,000 | 0.58% |